姓名：刘丽宏 性别：女 职称：主任药师、教授 招生院所：附属朝阳医院 招生类型：科学学位(博) 科学学位(硕) 招生专业：药理学(博) 药理学(硕) 研究方向名称：药理学；临床药学 电子信箱：hongllh@126.com


社会任职
1. 中国医院协会药事管理专业委员会委员
2. 国家科学技术奖励评审专家
3. 北京市药学会理事
4. 北京市药理学专业委员会理事
5. 北京市药学会老年药学专业委员会委员
6. 北京中医药协会药事管理委员会委员
7. 北京药理学会生殖药理专业委员会副主任委员
8. 北京医学会临床药学分会第一届委员会常务委员
9. 中国药学会科普工作委员会委员
10. 中国药理学会治疗药物监测研究专业第一届委员会委员
11. 中国药理学会药源性疾病学专业委员会第一届常务委员会委员
12. 北京药理学会第二届临床药理专业委员会常务委员
13. 中国女医师协会药学专业委员会主任委员
14. 中国民族医药学会芳香医药分会副会长
15. 北京医院协会医疗管理科学专业委员会副主任委员
16. 北京药师协会慢病防治药学专业委员会副主任委员
17. 北京药师协会药师教育专业委员会副主任委员
18. 中国药学会药物临床评价研究专业委员会PK/PD学组委员
19. 北京抗癌药物专业委员会常务委员
20. 北京医学会罕见病分会第二届委员会常务委员
21. 世界中医药学会联合会副主任委员
22. 北京药师协会第三届慢病防治药学管理委员会副主任委员
23. 中国研究型医院学会药物评价专业委员会副主任委员
24. 北京药理学会第三届理事会理事
25. 北京医学会临床药学分会副主任委员
26. 北京药学会医院药学专业委员会委员
27. 北京药学会应用与转化药学专业委员会主任委员
28. 北京市医院管理局药品供应与质量管理总药剂师
29. 中华医学会临床药学专委会委员
30. 北京市卫生经济学会药物经济学专业委员会委员
31. 吴阶平医学基金会临床药学专项基金专家委员会委员
32. 中国医药教育协会MTM培训中心副主任委员
33. 中国药学会药学服务专业委员会主任委员
34. 中国社会保障学会医疗保障专业委员会委员
35. 北京药师协会药物治疗管理专业委员会特聘专家
个人简历
1. 198609-199007:沈阳药科大学 本科学习
2. 199509-199707:西安医科大学 硕士研究生
3. 199809-200107:第四军医大学 博士研究生
4. 200108-200311:军事医学科学院 博士后
5. 200311-201202:第二炮兵总医院 药学部主任、药物临床试验机构办公室主任、Ⅰ期药物临床试验研究室主任
6. 201203-:首都医科大学附属北京朝阳医院 总药剂师、药事部主任
重要学术论文
1. Li-li Gong*, Song Yang, Wen Zhang, Fei-fei Han, Ya-li Lv, Ling-ling Xuan, He Liu, Li-hong Liu*.Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC–MS based lipidomics approach. Journal of Pharmaceutical and Biomedical Analysis. 2020,177:112848.SCI
2. Lingling Xuan, Lulu Ren, Feifei Han, Lili Gong, Zirui Wan, Song Yang, He Liu, Yali Lv*, Lihong Liu*.Cytomegalovirus Infection Exacerbates Experimental Colitis by Promoting IL-23 Production. Inflammation. 2020,43（1）:326-335.SCI
3. Zhikang Ye, Annika Reintam Blaser, Lyubov Lytvyn, Ying Wang, Gordon H. Guyatt, J. Stephen Mikita, Jamie Roberts, Thomas Agoritsas, Sonja Bertschy, Filippo Boroli, Julie Camsooksai, Bin Du, Anja Fog Heen, Jianyou Lu, José M. Mella, Per Olav Vandvik, Robert Wise, Yue Zheng, Lihong Liu*, Reed A.C. Siem.Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. BMJ. 2020,368:l6722.SCI
4. Ying Wang, Zhikang Ye, Long Ge, Reed A Siemieniuk, Xin Wang, Yingkai Wang, Liangying Hou, Zhuo Ma, Gordon H Guyatt, Lihong Liu*.Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis. BMJ. 2020,368:l6744.SCI
5. Li-li Gong, Song Yang, He Liu, Wen Zhang, Lu-lu Ren, Fei-fei Han, Ya-li Lv, Zi-Rui Wan, Li-hong Liu*.Anti-nociceptive and anti-inflammatory potentials of Akebia saponin D. Eur J Pharmacol. 2019,845:85-90.SCI
6. Lifang Guo, Zirui Wan, Benshan Xu, Lulu Ren, He Liu, Nan Song*, Lihong Liu*.Blockade of angiogenin by thalidomide inhibits the tumorigenesis of murine hemangioendothelioma. Fundam Clin Pharmacol. 2019,33（6））:659-669.SCI
7. Lifang Guo, Mingbiao Shi, Nan Song, Zirui Wan, He Liu*, Lihong Liu*.Anchorage of curcumin onto PVP enhances anti-tumor effect of curcumin. Medicinal Chemistry Research. 2019,28（5）:646-656.SCI
8. Lulu Ren, Feifei Han, Lingling Xuan, Yali Lv, Lili Gong, Yan Yan, Zirui Wan, Lifang Guo, He Liu, Benshan Xu, Yuan Sun,Song Yang, Lihong Liu*.Clusterin ameliorates endothelial dysfunction in diabetes by suppressing mitochondrial fragmentation. Free Radical Biology and Medicine. 2019,145:357-373.SCI
9. Ping Du, Pengfei Li, Rui Zhao, Hongchuan Liu, Lihong Liu*..Optimized UPLC-MS/MS method for the quantitation of olanzapine in human plasma: application to a bioequivalence study. Bioanalysis. 2019,11（13）:1291-1302.SCI
10. Song Yang, Wen Zhang, Ling-ling Xuan, Fei-fei Han, Ya-li Lv, Zi-rui Wan, He Liu, Lu-lu Ren, Li-li Gong∗, Li-hong Liu*.Akebia Saponin D inhibits the formation of atherosclerosis in ApoE-/- mice by attenuating oxidative stress-induced apoptosis in endothelial cells. Atherosclerosis. 2019,285:23-30.SCI
11. Jiaming Fan#, Pengfei Li#, He Liu, Rui Zhao, Zhixia Zhao, Ping Du, Lihong Liu**.Optimized liquid chromatography-electrospray quadrupole linear ion trap mass spectrometry method for the quantitation of paraquat in plasma: application to a toxicokinetic study. Analytical methods. 2019,11（12）:2756-2762 .SCI
12. Wen Zhang, Lili Gong, Song Yang, Yali Lv, Feifei Han, He Liu, Lihong Liu*.Lipidomics Profile Changes of Type 2 Diabetes Mellitus with Acute Myocardial Infarction. Disease Markers. 2019,2019:doi:10.1155/2019/**.SCI
13. Zhuoling An, Ting Hu, Yali Lv, Pengfei Li, Lihong Liu*.Targeted amino acid analysis based on iTRAQ-LC-MS/MS for discovering potential hepatotoxicity biomarkers. Journal of Pharmaceutical and Biomedical Analysis. 2019,178:112812.SCI
14. Xiangli Cui, Zirui Wan, Zhuo Ma, Lihong Liu*, Yuanhua Yang*.Occurrence of acute pulmonary embolism induced by recombinant erythropoietin during treatment of pure red cell aplasia associated with thymoma: A case report.. Medicine (Baltimore). 2019,98（10）:e14789.SCI
15. Ying Wang, Zhikang Ye, Lihong Liu*, Xiangli Cui*.Antidepressant Use and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis. J Pharm Pharm Sci. 2019,12（1）:57-71.SCI
16. Huaguang Wang, Han Wang, Xiaojia Yu, Hong Zhou, Boyu Li, Gang Chen, Zhikang Ye, Ying Wang, Xiangli Cui, Yunying Zheng, Rui Zhao, Hui Yang, Zihui Wang, Peng Wang, Chunxia Yang, Lihong Liu*.Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010–2016: a retrospective observational study. BMJ Open. 2019,9（8）:e026072.SCI
17. Hui Yang, Lili Li, Xiaopeng Hu, Wei Wang, Xiaoyong Yang, Hang Liu, Liang Ren, Xiaodong Zhang*, Lihong Liu*.Impact of pharmacist-led post-transplant medication management for kidney transplant recipients: A retrospective pre- and post-intervention study. J Clin Pharm Ther. 2019,44（4）:603-610.SCI
18. 郑芸颖，王华光，崔向丽，刘丽宏*.碳青霉烯类抗菌药物合理用药的分析. 中国临床药理学杂志. 2018,34(13):97-99.核心期刊
19. 赵志霞，宋 新，李鹏飞，赵 瑞，于伟越，周 鑫，刘丽宏*.生物等效性试验中受试者食用高脂餐的调查研究. 中国临床药理学杂志. 2018,34（24）:85-87.核心期刊
20. 郑芸颖，崔向丽，刘丽宏*.酚磺乙胺注射液引发呼吸困难等过敏反应的案例分析. 中国临床药理学杂志. 2018,34(13):348-349.核心期刊
21. 刘洪川，李鹏飞，杜 萍，赵 瑞，于伟越，刘丽宏*.高效液相色谱-质谱联用法测定人血浆中依普利酮浓度. 中国临床药理学杂志. 2018,34（10）:1226-1229.核心期刊
22. 陈罡，潘世芬，崔向丽，刘丽宏*."Puerarin attenuates angiotensin II-induced cardiac fibroblasts proliferation via the promotion of catalase activity and the inhibition of hydrogen peroxide-dependent Rac-1 activation. Chinese Journal of Natural Medicines. 2018,16（1）:41-52.SCI
23. 王颖，叶志康，崔向丽*，刘丽宏*.Heparin-induced thrombocytopenia: A critical appraisal of clinical practice guidelines with the AGREE II instrument. Thrombosis research. 2018,166:10-18.SCI
24. 刘洪川，李鹏飞，杜 萍，于伟越，赵 瑞，刘丽宏*.用HPLC-MS/MS法测定人尿液中依普利酮的浓度. 药学服务与研究. . 2018,18（1）:29-32.核心期刊
25. 安卓玲，李超，吕亚丽，李鹏飞，吴诚，刘丽宏*.Metabolomics of hydrazine-induced hepatotoxicity in rats for discovering potential biomarkers. Disease Markers. 2018,【未填写卷（期）】:**.SCI
26. 李博宇、王颖、叶志康、杨辉、崔向丽、王振军*、刘丽宏*.Effects of Canagliflozin on Fatty Liver Indexes in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials . J Pharm Pharm Sci. 2018,21（1）:225-235.SCI
27. 董亚玲#, 吕亚丽#, 周晓金#, 何林富#, 刘丽宏*, 李鹏飞.Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers . OncoTargets and Therapy. 2018,11:1743–1756.SCI
28. 杨辉，王伟，胡小鹏，张小东*，刘丽宏*.Sirolimus-induced severe small bowel angioedema:A case report. Medicine. 2018,97（34）:e12029.SCI
29. 宫丽丽、杨嵩、张文、韩菲菲、吕亚丽、万子睿、刘河、贾阳杰、玄玲玲、刘丽宏*.Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy. Journal of Pharmacological Sciences. 2018,136（4）:189-195.SCI
30. 田艳平，崔向丽，刘丽宏*.基于决策树模型对我国6种保肝药物治疗药物性肝损伤的成本-效果分析. 中国药物应用与监测. 2018,15（3）:131-135.核心期刊
31. 王华光，于晓佳，刘丽宏*.经皮冠状动脉介入治疗术后1例患者的药物重整. 药物不良反应杂志. 2017,11（241）:1019.核心期刊
32. 李博宇，崔向丽，邱爽，刘丽宏*.胸腺五肽注射液不合理用药干预分析. 中国临床药理学杂志. 2017,33（7）:653-655.核心期刊
33. 杨辉, 尹航, 崔向丽, 刘丽宏*.临床药师在肾内科疾病合理用药中的作用. 中国临床药理学杂志. 2017,33（13）:112-114.核心期刊
34. 郭梦园，邱爽*，崔向丽，刘丽宏.临床药师对1 例复发难治多发性骨髓瘤患者开展的药学服务. 临床药物治疗杂志. 2017,153（）:55-59.核心期刊
35. 杨辉, 崔向丽, 刘丽宏*.美国患者教育模式对我国的借鉴意义. 中国临床药理学杂志. 2017,33（11）:116-118.核心期刊
36. 崔向丽，王诗卉，刘丽宏*.案例教学法在临床药师实习教学中的应用. 中国临床药理学杂志. 2017,33（7）:659-661.核心期刊
37. 崔向丽1，万子睿1，侯珂露1，杨辉1，于晓佳1，郑芸颖1，刘丽宏1*，杨媛华*.增加肿瘤患者血栓风险的药物概述. 中国药物警戒. 2017,14（7）:1-7.核心期刊
38. 郭梦园，崔向丽，刘丽宏*，刘莹.3例精准用药门诊药物治疗管理案例分析. 实用药物与临床杂志. 2017,20（2）:236-240.核心期刊
39. 王鑫，崔向丽，杨辉，刘丽宏*.肾移植术后肺部感染的研究现状. 中国临床药理学杂志. 2017,33（3）:276-279.核心期刊
40. Xin Wang, Hui Yang, Xiaodong Zhang, Xiangli Cui, Shihui Wang, Lihong Liu*.Effectiveness of Valganciclovir 900mg Versus 450mg for Cytomegalovirus Prophylaxis in Renal Transplantation: A Systematic Review and Meta-Analysis . J Pharm Pharm Sci. 2017,20:168-183. .SCI
41. Li P, Hoppmann S, Du P, Li H, Evans PM, Moestue SA, Yu W, Dong F, Liu H, Liu L*..Pharmacokinetics of Perfluorobutane after Intra-Venous Bolus Injection of Sonazoid in Healthy Chinese Volunteers. Ultrasound Med Biol. 2017,43（5）:1031-1039.SCI
42. Li-li Gong, Fei-fei Han, Ya-li Lv, He Liu, Zi-rui Wan, Wen Zhang, Ming-biao Shi, Li-xia Pei, Li-hong Liu*.TNF-alpha and LT-alpha polymorphisms and the risk of leukemia: a meta-analysis.. TUMORI. 2017,103（1）:53-59.SCI
43. 侯珂露，杨辉，叶志康，王颖，刘丽宏*，崔向丽*.Effectiveness of Pharmacist-led Anticoagulation Management on Clinical Outcomes: A Systematic Review and Meta-Analysis. Journal of Pharmacy & Pharmaceutical Sciences. 2017,20:378-396.SCI
44. Hui Yang, Xiangli Cui, Xin Wang, Shuang Qiu, Lihong Liu*..Clinical Outcomes with Antiviral Prophylaxis or Preemptive Therapy for Cytomegalovirus Disease after Liver Transplantation: A Systematic Review and Meta-Analysis. J Pharm Pharm Sci. 2017,20(1):15 - 27.SCI
45. Han FF, Lv YL, Gong LL, Liu H, Wan ZR, Liu LH*..VDR Gene variation and insulin resistance related diseases.. Lipids Health Dis. 2017,16(1):157.SCI
46. Yang-jie Jia, Jun Liu, Fei-fei Han, Zi-rui Wan, Li-li Gong, He Liu, Wen Zhang, Thomas Wardell, Ya-li Lv*，, Li-hong Liu* .Cytomegalovirus infection and atherosclerosis risk: a meta-analysis. J Med Virol. 2017,89(12):2196-2206.SCI
47. Ya-li Lv, Fei-fei Han, Li-li Gong, He Liu, Jun Ma, Wei-yue Yu, Zi-rui Wan, Yang-jie Jia, Wen Zhang, Mingbiao Shi, Li-hong Liu*.Human cytomegalovirus infection and vascular disease risk: A meta-analysis. Virus Research. 2017,227:124-134.SCI
48. Gong LL, Liu H, Liu LH*.Relationship between hypothyroidism and the incidence of gestational diabetes: A meta-analysis.. Taiwan J Obstet Gynecol.. 2016,55(2):171-175.SCI
49. Zhi-Kang Ye, Ying Liu, Xiang-Li Cui, Li-Hong Liu*.Critical Appraisal of the Quality of Clinical Practice Guidelines for Stress Ulcer Prophylaxis. PLoS ONE. 2016,11（5）:e**.SCI
50. Hui Yang, Xiangli Cui, Zhuo Ma, Lihong Liu*.Evaluation Outcomes Associated with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Systematic Review and Meta-Analysis. J Pharm PharmSci. 2016,19（2）:274-289.SCI
51. Gong LL, Li GR, Zhang W, Liu H, Lv YL, Han FF, Wan ZR, Shi MB, Liu LH*.AkebiaSaponin D Decreases Hepatic Steatosis through Autophagy Modulation.. J Pharmacol Exp Ther.. 2016,359(3):392-400.SCI
52. Gong LL,Han FF, Lv YL, Liu H, Wan ZR, Zhang W,ShiMB,PeiLX,Liu LH*.TNF-α and LT-α polymorphisms and the risk of leukemia: a meta-analysis.. Tumori.. 2016,103(1):53-59.SCI
53. YALI LV, LILI GONG, ZIHUI WANG, FEIFEI HAN, HE LIU, XUECHUN LU, LIHONG LIU*.Curcumin inhibits human cytomegalovirus bydownregulating heat shock protein 90 . MOLECULAR MEDICINE REPORTS. 2015,12（3）:4789-4793.SCI
54. Gang Chen, Qiang Cao, Xiangli Cui, Shifen Pan, Chong Shen, Lihong Liu*.Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways. Journal of pharmacy and pharmaceutical sciences. 2015,18（2）:235 - 248.SCI
55. 李广润,宫丽丽,吕亚丽,刘丽宏* .川续断皂苷Ⅵ药理作用研究进展. 中国新药与临床杂志. 2014,33（7）:477-480.核心期刊
56. 王华光,刘丽宏*.临床药师参与抗菌药物使用管理的经验和体会. 药学服务与研究. 2014,14（2）:101-103.核心期刊
57. 李广润,宫丽丽,吕亚丽,刘河,韩菲菲,王子惠,刘丽宏*.川续断皂苷VI对非酒精性脂肪肝小鼠的降脂作用研究. 时珍国医国药. 2014,25（8）:1800-1802.核心期刊
58. Lv Y, An Z, Chen H, Wang Z, Liu L*.Mechanism of curcumin resistance to human cytomegalovirus in HELF cells. BMC Complement Altern Med.. 2014,14:284.SCI
59. Han FF, Fan H, Wang ZH, Li GR, Lv YL, Gong LL, Liu H, He Q*, Liu LH*.Association between co-stimulatory molecule gene polymorphism and acute rejection of allograft. Transpl Immunol. 2014,31（2）:81-86.SCI
60. 李鹏飞, 王淑民, 张茜, 安卓玲, 刘丽宏*.LC-MS/MS法测定人血浆中氨基葡萄糖的浓度. 首都医科大学学报. 2013,34(5):715-719.核心期刊
61. Fei-fei Han, Chang-long Guo, Li-hong Liu*.The Effect of CHEK2 Variant I157T on Cancer Susceptibility: Evidence from a Meta-Analysis. DNA and Cell Biology. 2013,32(6):329-335.SCI
62. 罗薇, 王鹤尧*, 刘丽宏*, 李鹏飞, 祝锦, 宫丽丽.CYP2C19多态性对奥美拉唑药代动力学的影响. 临床药物治疗杂志. 2013,11(2):22-26.核心期刊
63. Fei-fei Han, Chang-long Guo, Li-Li Gong, Jin Zhu, Li-hong Liu*.Effects of the NQO1 609C>T Polymorphism on Leukemia Susceptibility: Evidence from a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 2013,14(9):5311-5316.SCI
64. Pengfei Li, Beibei Tao, Xude Zhang, Zhuoling An, Xi Zhang, Yue Li, Hao Qianqian, Lihong Liu*.High-flux Detection of 30 Kinds Amino Acids with Isotope-Labeled Internal Standard by LC-MS/MS.. Chinese Journal of Analytical Chemistry. 2013,41(9):1347-1352.SCI
65. 张征, 李馨, 李鹏飞, 于晓佳, 邱葵, 罗薇, 刘丽宏*.中毒患者血浆中百草枯的LC-MS/MS定量检测方法研究. 国际检验医学杂志. 2013,34(11):1380-1381.核心期刊
66. 张茜, 李鹏飞, 吕亚丽, 安卓玲, 吴诚, 李广润, 刘丽宏*.硝胺推进剂在大鼠体内代谢动力学及病理学研究. 国际检验医学杂志. 2013,34(3):263-265.核心期刊
67. Li-Li Gong, Lian-Hua Fang, He-Yao Wang, Jian-Hao Peng, Kun Si, Jin Zhu, Fei-Fei Han, Yue-Hua Wang, Guan-Hua Du*, Li-Xia Pei, Li-Hong Liu*. Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis. Steroid. 2013,2013(78):401-408.SCI
68. 张征, 刘颖, 张倩, 刘丽宏*.荧光素钠注射液致不良反应55例分析. 中国药房. 2013,24(44):4189-4191.核心期刊
69. 陈慧, 童卫杭, 刘丽宏*.盐酸吉西他滨致手足综合征1例. 中国医院药学杂志. 2013,33(9):755-756.核心期刊
70. 路敏, 雷宁, 吕亚丽, 吴诚, 李超, 刘丽宏*.续断皂苷类成分的体外抗氧化活性研究. 北京师范大学学报:自然科学版. 2013,49(1):42-45.核心期刊
71. 吕亚丽, 蓝苑元, 王丹, 雷宁, 刘丽宏*.姜黄素体外抗人巨细胞病毒活性的研究. 中药新药与临床药理. 2012,23(5):531-533.核心期刊
72. Peng-Fei Li, Jian-Zi Sun, Ling Wang, Ya-Li Lv, Li-Hong Liu*.3,5-Bis(adamantan-1-yl)-1 -methoxy-benzene. Acta Crystallographica Section E. 2012,E68:01182.SCI
73. 马萍, 李鹏飞, 王淑民, 汪娟, 王燕, 谢晓娟, 刘丽宏*.克拉霉素软胶囊在中国健康人体的生物等效性研究. 中国临床药理学与治疗学. 2012,17(4):433-437.核心期刊
74. Pengfei Li, Yan Wang, Beibei Tao, Jing Wang, Jing Luo, Xude Zhang, Zhuoling An, Lihong Liu*.Simultaneous Determination of 42 Amino Acids in Human Body by Stable Isotope Isobaric Tage for Relative and Absolute Quantitation Labeled-LC-MS/MS with Typical Example Cases. Chinese Journal of Analytical Chemistry. 2012,40(5):762-767.SCI
75. 安卓玲, 李鹏飞, 迟小华, 张茜, 马萍, 刘丽宏*.肼引发损伤相关小分子代谢物的研究进展. 中国药理学通报. 2012,28(6):754-756.核心期刊
76. Pengfei Li, Ping Ma, Yan Wang, Weihang Tong, Jing Wang, Cheng Wu, Lihong Liu*.Liquid chromatography-electrospray quadrupole linear ion trap mass spectrometry method for the quantitation of palonosetron in human plasma and urine: Application to a pharmacokinetic study . Journal of Chromatography B. 2012,895-896:10-6.SCI
77. 吴诚, 李鹏飞, 王燕, 雷宁, 吕亚丽, 刘丽宏*.液相色谱-质谱联用法测定大鼠血浆中木通皂苷D的浓度. 国际药学研究杂志. 2012,39(3):261-264.核心期刊
78. 王波, 李鹏飞, 马萍, 王燕, 刘丽宏*.LC-MS/MS和荧光偏振法监测环孢素A血药浓度的相关性研究. 质谱学报. 2012,33(1):28-31.核心期刊
79. 雷宁, 王玲, 孙健姿, 吴诚, 刘丽宏*.六味参苓颗粒的质量标准研究. 中国药房. 2012,23(35):3328-3330.核心期刊
80. Kang Meng, Miao Cao, Zhuo-Ling An, Jie Zhang, Li-Hong Liu*.(5-Bromo-2-hydroxyphenyl)(4-propyl-cyclohexyl) methanone. Acta Crystallographica Section E. 2012,E68:01181.SCI
81. Li-Li Gong, Jian-Hao Peng, Fei-Fei Han, Jin Zhu, Lian-Hua Fang, Yue-Hua Wang, Guan-Hua Du*, He-Yao Wang*, Li-Hong Liu*.Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis. Thrombosis Research. 2012,130(3):e43-51.SCI
82. 王燕, 李鹏飞, 马萍, 安卓玲, 胡范文, 刘丽宏*. LC-MS/MS法检测他克莫司血药浓度室内质控回顾性分析. 国际检验医学杂志. 2012,33(15):1873-1875.核心期刊
83. Ya-li LV, An-jie LAN, Yuan-yuan LAN, Chao LI, Ning LEI, Cheng WU and Li-hong LIU*.Activity of curcumin against human cytomegalovirus in vitro. African Journal of Pharmacy and Pharmacology. 2012, 6(1):30-35.SCI
84. 王燕, 李鹏飞, 马萍, 安卓玲, 张茜, 罗恋, 刘丽宏*.LC-MS/MS法测定人血浆中氨氯地平的浓度. 质谱学报. 2012,33(3):181-185.核心期刊
85. 李鹏飞, 孙健姿, 马萍, 王燕, 王静, 张茜, 谢小娟, 刘丽宏*.LC-MS/MS法测定人血浆中克拉霉素的质量浓度. 北京师范大学学报:自然科学版. 2012,48(4):323-326.核心期刊
86. 马萍, 李鹏飞, 童卫杭, 孙健姿, 吴诚, 刘丽宏*.氯沙坦钾片在健康人体的生物等效性. 中国临床药理学杂志. 2012,28(3):179-182.核心期刊
87. 李鹏飞, 王燕, 童卫杭, 马萍, 兰安杰, 刘丽宏*.液相色谱-串联质谱法测定人血浆中多潘立酮浓度. 中国临床药理学杂志. 2012,28(3):208-211.核心期刊
88. 蓝苑元, 罗恋, 吕亚丽, 马萍, 刘丽宏*.姜黄素自微乳化制剂制备及其稳定性研究. 中国药师. 2012,15(2):173-177.核心期刊
89. 李超, 张晓菲, 吕亚丽, 蓝苑元, 雷宁, 刘丽宏*.木通皂苷D对CCl4致小鼠急性肝损伤的保护作用. 华西药学杂志. 2012,27(3):257-259.核心期刊
90. 童卫杭, 温洁怡, 宝玉荣, 李鹏飞, 马萍, 王燕, 刘丽宏*.来曲唑片在中国健康人体的生物等效性. 中国临床药理学杂志. 2012,28(2):131-134.核心期刊
91. Kang Meng, Cheng Wu, Jing Cao, Ping Ma, Lihong Liu*.Bis(4-ethoxyphenyl) sulfoxide. Acta Crystallographica Section E. 2011,E67:01136.SCI
92. Xiao-fei Zhang, Chun-lei Ding, He Liu, Li-hong Liu*.Protective effects of ion-imprinted chitooligo-saccharides as uranium-specific chelating agents against the cytotoxicity of depleted uranium in human kidney cells. Toxicology. 2011,286(1-3):75-84.SCI
主编或副主编的著作/译著
1. 《解密朝阳之临床思维构建》,主编,科学技术文献出版社,201806
2. 《解密朝阳药学变革之路》,主编,科学技术文献出版社,201708
3. 《哮喘用药咨询标准化手册》,主编,人民卫生出版社,201703
4. 《药—千错万错别吃错》,主编,中国协和医科大学出版社,201605
重要奖项
1. 放射性核素氚体内促排制剂（排氚片）的研究 军队医疗成果奖 三等奖 201210
2. 液体推进剂损伤诊断标准与处理原则 军队科技进步奖 三等奖 201210
3. 鲍曼不动杆菌多重耐药机制及临床用药选择研究 军队医疗成果奖 三等奖 200810
4. 氯麻鼻用凝胶剂（瑞利敏）的制剂学和临床研究 军队医疗成果奖 三等奖 200710
5. 二氢吡啶类钙拮抗剂抗5-HT2B受体的作用及其防治高血压的机制 军队医疗成果奖 三等奖 200601